The new combined unit will operate as GCI Health Middle East.
The move comes at a critical time when healthcare is one of the fastest-growing sectors in the world, accelerated by the COVID-19 pandemic and vaccines.
“The launch of GCI Health Middle East enhances our capacity to deliver exceptional health-focused communications in the region at a time when governments are investing significantly in healthcare infrastructure,” said Kristin Cahill, Global CEO, GCI Health.
GCI Health Middle East will be led by Kath Kerry, president of Europe & Middle East for GCI Health, in partnership with Sunil John, founder of ASDA’A BCW.
“Healthcare communications has been one of our strengths as an agency over the past 21 years, and we have been working with health ministries in the region, as well as some of the largest healthcare providers, pharmaceutical and MedTech companies,” John told Arab News.
Its clients include the Saudi Ministry of Health, G42 Health in Abu Dhabi, AstraZeneca, Edwards Lifesciences, Roche Diagnostics, Novo Nordisk, Merck, Boehringer Ingelheim, Allergan Aesthetics and GE Healthcare.
“In today’s fast-paced and changing environment following the pandemic, and with the wellness of the public being top priority for governments, there is a stronger need for specialized healthcare and medical communications consultancy,” John added.
The GCI Health Middle East team consists of eight employees based in Dubai with a total of 25 employees across its network of offices in the Middle East and North Africa (MENA) region.